Sigmapharm Labs Llc Company Profile
✉ Email this page to a colleague
What is the competitive landscape for SIGMAPHARM LABS LLC
SIGMAPHARM LABS LLC has sixteen approved drugs.
There is one tentative approval on SIGMAPHARM LABS LLC drugs.
Drugs and US Patents for Sigmapharm Labs Llc
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Sigmapharm Labs Llc | ASENAPINE MALEATE | asenapine maleate | TABLET;SUBLINGUAL | 206107-001 | Dec 10, 2020 | AB | RX | No | No | ⤷ Start Trial | ⤷ Start Trial | ||||
| Sigmapharm Labs Llc | POTASSIUM CHLORIDE | potassium chloride | TABLET, EXTENDED RELEASE;ORAL | 207528-002 | Aug 19, 2016 | DISCN | No | No | ⤷ Start Trial | ⤷ Start Trial | |||||
| Sigmapharm Labs Llc | DISULFIRAM | disulfiram | TABLET;ORAL | 091619-001 | Mar 28, 2011 | AB | RX | No | No | ⤷ Start Trial | ⤷ Start Trial | ||||
| Sigmapharm Labs Llc | DOFETILIDE | dofetilide | CAPSULE;ORAL | 207746-003 | Mar 26, 2018 | AB | RX | No | No | ⤷ Start Trial | ⤷ Start Trial | ||||
| Sigmapharm Labs Llc | FLUCYTOSINE | flucytosine | CAPSULE;ORAL | 201566-002 | Jun 28, 2011 | AB | RX | No | No | ⤷ Start Trial | ⤷ Start Trial | ||||
| Sigmapharm Labs Llc | NITROGLYCERIN | nitroglycerin | TABLET;SUBLINGUAL | 207745-002 | May 7, 2018 | DISCN | No | No | ⤷ Start Trial | ⤷ Start Trial | |||||
| >Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |
Similar Applicant Names
Here is a list of applicants with similar names.

